Extra-cranial malignant rhabdoid tumors (MRTs) exhibit molecular heterogeneity
Evidence is presented for epigenetic reprogramming of HOX genes
MRTs exhibit dysregulated expression of genes involved in neural crest development
Dysregulation of oncogenes and tumor suppressor genes is reported